Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2025-2033

Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5834

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Cancer Biomarkers Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Profiling Technology
    6.1    Omic Technologies
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Imaging Technologies
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Immunoassays
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Cytogenetics
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Biomolecule
    7.1    Genetic Biomarkers
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Protein Biomarkers
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Glyco-Biomarkers
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Cancer Type
    8.1    Breast Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Lung Cancer
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Colorectal Cancer
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Prostate Cancer
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Stomach Cancer
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9   Market Breakup by Application
    9.1    Diagnostics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Prognostics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Risk Assessment
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Drug Discovery and Development
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10  Market Breakup by End User
    10.1    Hospitals
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Academic and Research Institutions
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Ambulatory Surgical Centers
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Diagnostic Laboratories
        10.4.1 Market Trends
        10.4.2 Market Forecast
    10.5    Others
        10.5.1 Market Trends
        10.5.2 Market Forecast
11  Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12  SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15  Price Analysis
16  Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Abbott Laboratories
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Agilent Technologies Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials
           16.3.2.4 SWOT Analysis
        16.3.3    Becton Dickinson and Company
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
           16.3.3.3 Financials
           16.3.3.4 SWOT Analysis
        16.3.4    bioMérieux SA
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
           16.3.4.4 SWOT Analysis
        16.3.5    Danaher Corporation
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
           16.3.5.3 Financials
           16.3.5.4 SWOT Analysis
        16.3.6    F. Hoffmann-La Roche AG
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
           16.3.6.3 SWOT Analysis
        16.3.7    General Electric Company
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 Financials
           16.3.7.4 SWOT Analysis
        16.3.8    Illumina Inc.
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Qiagen N.V.
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
           16.3.9.4 SWOT Analysis
        16.3.10    Sino Biological Inc.
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
        16.3.11    Thermo Fisher Scientific Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
           16.3.11.4 SWOT Analysis

List of Figures

​Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2024
Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2024
Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2024
Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2024
Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2024
Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2024
Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2024
Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million USD), 2025-2033
Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million USD), 2025-2033
Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Cancer Biomarkers Market: Competitive Structure
Table 9: Global: Cancer Biomarkers Market: Key Players

Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials